Joel Greenblatt's AVNS Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 10,050 shares of Avanos Medical, Inc. (AVNS) worth $116,178, representing 0.00% of the portfolio. First purchased in 2018-Q3, this long-term strategic position has been held for 29 quarters.
Based on 13F filings, Joel Greenblatt has maintained a strategic position in AVNS, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 46,005 shares. Largest reduction occurred in Q1 2019, reducing 114,260 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Avanos Medical (AVNS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Avanos Medical (AVNS) Trades by Joel Greenblatt
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2018 | +232,529 | New Buy | 232,529 | $68.50 |
| Q4 2018 | -67,568 | Reduce 29.06% | 164,961 | $44.79 |
| Q1 2019 | -114,260 | Reduce 69.26% | 50,701 | $42.68 |
| Q2 2019 | -50,701 | Sold Out | 50,701 | $0.00 |
| Q4 2021 | +15,731 | New Buy | 15,731 | $34.64 |
| Q1 2022 | +22,631 | Add 143.86% | 38,362 | $33.50 |
| Q2 2022 | -12,389 | Reduce 32.29% | 25,973 | $27.34 |
| Q3 2022 | +1,434 | Add 5.52% | 27,407 | $21.78 |
| Q4 2022 | -6,057 | Reduce 22.10% | 21,350 | $27.06 |
| Q1 2023 | -8,085 | Reduce 37.87% | 13,265 | $29.74 |
| Q2 2023 | -3,912 | Reduce 29.49% | 9,353 | $25.56 |
| Q3 2023 | -9,353 | Sold Out | 9,353 | $0.00 |
| Q4 2023 | +16,167 | New Buy | 16,167 | $22.43 |
| Q1 2024 | +17,821 | Add 110.23% | 33,988 | $19.91 |
| Q2 2024 | -6,460 | Reduce 19.01% | 27,528 | $19.92 |
| Q3 2024 | -719 | Reduce 2.61% | 26,809 | $24.03 |
| Q4 2024 | +1,425 | Add 5.32% | 28,234 | $15.92 |
| Q1 2025 | -6,073 | Reduce 21.51% | 22,161 | $14.33 |
| Q2 2025 | +46,005 | Add 207.59% | 68,166 | $12.24 |
| Q3 2025 | -58,116 | Reduce 85.26% | 10,050 | $11.56 |
Joel Greenblatt's Avanos Medical Investment FAQs
Joel Greenblatt first purchased Avanos Medical, Inc. (AVNS) in Q3 2018, acquiring 232,529 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Avanos Medical, Inc. (AVNS) for 29 quarters since Q3 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's largest addition to Avanos Medical, Inc. (AVNS) was in Q3 2018, adding 232,529 shares worth $15.93 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 10,050 shares of Avanos Medical, Inc. (AVNS), valued at approximately $116,178. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Avanos Medical, Inc. (AVNS) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's peak holding in Avanos Medical, Inc. (AVNS) was 232,529 shares, as reported at the end of Q3 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.